The name sounds like equipment from a lab, and shockwave is often sold as high-tech. Readers around Mount Prospect ask what extracorporeal shockwave therapy actually is.
A proposed treatment, in the paper's words
ESWT is the short form of the name. A paper on NIH PMC describes it as a proposed treatment rather than a settled one: "Extracorporeal shock wave therapy (ESWT) has been proposed as a potential method of treating patients with chronic disease without the need to stop weightbearing."
The wording is careful. "Proposed" and "potential" mark this as an idea under study, not a guarantee. The appeal named there is that patients need not stop weightbearing.
What the trials say
Two studies in NIH PMC look at ESWT for plantar fasciitis.
- One is an open label randomized trial of focused ESWT on myofascial points for plantar fasciitis.
- The other is a meta-analysis of randomized trials titled "Extracorporeal Shock Wave Therapy Is Effective In Treating Chronic Plantar Fasciitis."
Read that second title as the authors' conclusion, not as a promise for your foot. A meta-analysis of randomized trials is the kind of source worth asking a clinic about.
What to ask next
Ask which condition shockwave is meant to treat in your case. Ask whether the device used matches the type tested in the trials. Ask how many sessions are planned and how progress will be judged.
How the label reads against the evidence
Words like "advanced" are labels. The evidence worth weighing is the trial design and the condition studied. For plantar fasciitis there are randomized trials to read, and you can ask a clinic to point you to them.